Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Equity: 2017-2025

Historic Return on Equity for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to -0.31%.

  • cbdMD's Return on Equity rose 118.00% to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year increase of 118.00%. This contributed to the annual value of -0.44% for FY2025, which is 23.00% up from last year.
  • Latest data reveals that cbdMD reported Return on Equity of -0.31% as of Q3 2025, which was up 31.50% from -0.45% recorded in Q2 2025.
  • In the past 5 years, cbdMD's Return on Equity ranged from a high of -0.13% in Q1 2025 and a low of -6.35% during Q2 2024.
  • Over the past 3 years, cbdMD's median Return on Equity value was -1.44% (recorded in 2024), while the average stood at -1.91%.
  • In the last 5 years, cbdMD's Return on Equity tumbled by 551bps in 2024 and then soared by 591bps in 2025.
  • Over the past 5 years, cbdMD's Return on Equity (Quarterly) stood at -0.35% in 2021, then tumbled by 154bps to -1.89% in 2022, then slumped by 59bps to -2.49% in 2023, then spiked by 105bps to -1.44% in 2024, then skyrocketed by 118bps to -0.31% in 2025.
  • Its Return on Equity stands at -0.31% for Q3 2025, versus -0.45% for Q2 2025 and -0.13% for Q1 2025.